Megan Othus 1100 Fairview Avenue North M3-C102 PO BoxSeattle, WAEducation

First Page		Document Content
Date: 2015-08-12 14:04:03 Acute myeloid leukemia Chemotherapy regimen Leukemia Draft:Alexandros Makriyannis		Megan Othus 1100 Fairview Avenue North M3-C102 PO BoxSeattle, WAEducation Add to Reading List Source URL: www.swogstat.org Download Document from Source Website File Size: 71,83 KB Share Document on Facebook

	The Dual E-selectin/CXCR4 Antagonist GMI-1359 Exerts Anti-leukemia Efficacy Against FLT3-ITDmutated Acute Myeloid Leukemia in A Patient-derived Xenograft Murine Model Mouse-1 Mouse-2 DocID: 1uSbg - View Document
	A Phase I/II Study of GMI-1271, a Novel E-selectin Antagonist, in Combination with Induction Chemotherapy in Relapsed/Refractory and Previously Untreated Elderly Patients with Acute Myeloid Leukemia; Results to Date Dan DocID: 1uJQ2 - View Document
	Vascular E-Selectin Mediates Chemo-Resistance in Acute Myeloid Leukemia Initiating Cells Via Canonical Receptors PSGL-1 (CD162) and Hcell (CD44) and AKT Signaling Ingrid G Winkler, PhD1, Johanna M Erbani, PhD student2, DocID: 1u5Xi - View Document
	Microsoft Word - Publikationsliste_Leukämie.doc DocID: 1rn6f - View Document
	Megan Othus 1100 Fairview Avenue North M3-C102 PO BoxSeattle, WAEducation DocID: 1rb02 - View Document